Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Aralez Pharmaceuticals
Yahoo Beta:1.21

Company Description:  Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada, Ireland, and the United States. The company engages in acquiring, developing, and commercializing products primarily in cardiovascular disease, pain, and other specialty areas.

Purchase Date:30 Jan 2013 Sale Date:17 Jun 2015
Purchase Price:$5.37 Sale Price:$10.50
  --Split Adjusted:$5.37  --Split Adjusted:$10.50
Shares Purchased:550 Shares Sold:300
  --Split Adjusted:550  --Split Adjusted:300
Transaction Fee:$9.99 Transaction Fee:$10.05
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$6.77 High$0.00
Date17 Aug 2012 Date01 Jan 1996
Low$4.98 Low$0.00
Date28 Dec 2012 Date01 Jan 1996
S&P (Purchase Date):$1,501.96 S&P (Sale Date):$2,100.44

Timing:  We bought in the middle of the six month range.
Reason:  We were highly impressed by the company's pipeline of future drugs.

Timing:  0
Reason:  We partially divested given that the company has had trouble getting its newest drug approved. We are hedging against the possibility that the approval is not granted.

S&P Gain: 39.85 % Annualized Gain: 15.75%
Stock Gain: 95.53 % Annualized Gain: 33.97%

Net Holding Return ($): $1,518.96
Net Holding Return (%): 93.71 %